The panel of target cells include: HMEC-1 and bEnd.3, representing, respectively, healthy human and mouse cells with physiological levels of ICAM-1 (~104 molecules per cell); anaplastic thyroid carcinoma (8505 C) expressing an intermediate level (~105 per cell); and cervical cancer (HeLa) cell lines expressing a high level of ICAM-1 (~106 per cell). Here, ICAM1 is linked to cervical carcinoma.